Literature DB >> 3140837

Benign tertiary syphilis and HIV infection.

S Dawson1, B A Evans, A G Lawrence.   

Abstract

Benign tertiary (gummatous) syphilis has virtually disappeared [1]. Two homosexual men with gummata have presented to genitourinary medicine clinics in west London in recent months. They both had antibodies to HIV. It is possible that otherwise adequately treated syphilis has progressed to the tertiary stage as a consequence of HIV infection and modification of the immune response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140837     DOI: 10.1097/00002030-198808000-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  [Syphilis. Clinical aspects of Treponema pallidum infection].

Authors:  H Schöfer
Journal:  Hautarzt       Date:  2004-01       Impact factor: 0.751

Review 2.  Syphilis in adults.

Authors:  B T Goh
Journal:  Sex Transm Infect       Date:  2005-12       Impact factor: 3.519

3.  Pressure ulcer-like presacral gummata in a patient with tertiary syphilis.

Authors:  Uwe Wollina; André Koch; Mohammed Badawy Abdel-Naser; Jacqueline Schönlebe
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

Review 4.  The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity.

Authors:  J Andrew Carlson; Ganary Dabiri; Bernard Cribier; Stewart Sell
Journal:  Am J Dermatopathol       Date:  2011-07       Impact factor: 1.533

5.  Specific immunofluorescence staining of Treponema pallidum in smears and tissues.

Authors:  F Ito; E F Hunter; R W George; B L Swisher; S A Larsen
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

Review 6.  Laboratory diagnosis and interpretation of tests for syphilis.

Authors:  S A Larsen; B M Steiner; A H Rudolph
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 7.  Management issues in syphilis.

Authors:  David Pao; Beng T Goh; James S Bingham
Journal:  Drugs       Date:  2002       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.